Pronova BioPharma ASA (extinct)

Pronova BioPharma ASA (extinct)

Pronova BioPharma ASA (extinct)

Overview
Headquarters

Vollsveien 6,Lysaker, Akershus 1366

Type of Company

Private

Industries

Pharmaceuticals

Company Description

Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded on March 14, 2005 and is headquartered in Lysaker, Norway.

Contact Data
Trying to get in touch with decision makers at Pronova BioPharma ASA? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Paths to Pronova BioPharma ASA
Potential Connections via
Relationship Science
You
Pronova BioPharma ASA
Recent Transactions
Details Hidden

Pronova BioPharma ASA issued Ordinary Shares

Transaction Advisors
Investment Advisor

Advised onBASF SE, BASF AS purchase Pronova BioPharma ASA from Herkules Capital

Underwriter

Advised onPronova BioPharma ASA issued Ordinary Shares

Legal Advisor

Advised onBASF SE, BASF AS purchase Pronova BioPharma ASA from Herkules Capital

Advisors & Consultants
Legal Advisor

Partner at Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Legal Advisor

Partner at Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Investors
Details Hidden

HC is an active, long-term manager which targets large- and mid-cap public and private companies in the Nordic region, with a particular focus on Norway. The firm typically seeks to avoid hostile takeovers, preferring to take a controlling interest in well-established companies with positive cash flow and potential for further growth.HC aims to make equity or equity-related investments of NOK 100-850 million and seeks to own more than 50% of the shares in their portfolio companies, either alone or with partners.The firm's aims to avoid asset-intensive and cyclical industries, and although not sector-specific, they pay particular attention to the oil services, health care, consumer, trade/retail, services and telecom sectors.HC generally targets a five- to seven-year holding period for each investment.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Pronova BioPharma ASA. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Pronova BioPharma ASA's profile does not indicate a business or promotional relationship of any kind between RelSci and Pronova BioPharma ASA.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/pronova-biopharma-asa-498151
  • https://relationshipscience.com/organization/pronova-biopharma-asa-498151